APO Research

APO RESEARCH · REPORT

AI Imaging and Diagnostics System

Selected research

Market Analysis & Forecast

Global AI Imaging and Diagnostics System Market Analysis and Forecast 2026-2032

Market perspective

The global AI Imaging and Diagnostics System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Imaging and Diagnostics System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Imaging and Diagnostics System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Imaging and Diagnostics System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Imaging and Diagnostics System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Imaging and Diagnostics System include Siemens Healthineers AG, GE Healthcare, IBM Watson Health, Philips Healthcare, AliveCor Inc., Zebra Medical Vision, Inc., Riverain Technologies, Vuno, Inc. and Aidoc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Imaging and Diagnostics System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Imaging and Diagnostics System, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Imaging and Diagnostics System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Imaging and Diagnostics System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Imaging and Diagnostics System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Imaging and Diagnostics System revenue, projected growth trends, production technology, application and end-user industry.

AI Imaging and Diagnostics System Segment by Company

Siemens Healthineers AG

GE Healthcare

IBM Watson Health

Philips Healthcare

AliveCor Inc.

Zebra Medical Vision, Inc.

Riverain Technologies

Vuno, Inc.

Aidoc

Neural Analytics

Imagen Technologies

Digital Diagnostics, Inc.

Google (Subsidiary of Alphabet, Inc.)

Heartflow

Digital Diagnostics (Formerly Known as Idx)

AI Imaging and Diagnostics System Segment by Type

Hardware

Software

AI Imaging and Diagnostics System Segment by Application

Hospitals

Diagnostic Centers

Others

AI Imaging and Diagnostics System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Imaging and Diagnostics System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Imaging and Diagnostics System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Imaging and Diagnostics System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Imaging and Diagnostics System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Imaging and Diagnostics System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Imaging and Diagnostics System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Imaging and Diagnostics System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hardware Major Player Table 3. Software Major Player Table 4. Global AI Imaging and Diagnostics System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Diagnostic Centers Major Player Table 7. Others Major Player Table 8. AI Imaging and Diagnostics System Industry Trends Table 9. AI Imaging and Diagnostics System Industry Drivers Table 10. AI Imaging and Diagnostics System Industry Opportunities and Challenges Table 11. AI Imaging and Diagnostics System Industry Restraints Table 12. Global AI Imaging and Diagnostics System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global AI Imaging and Diagnostics System Market Size by Region (2021-2026) & (US$ Million) Table 14. Global AI Imaging and Diagnostics System Market Share by Region (2021-2026) Table 15. Global AI Imaging and Diagnostics System Market Size by Region (2027-2032) & (US$ Million) Table 16. Global AI Imaging and Diagnostics System Market Share by Region (2027-2032) Table 17. Global AI Imaging and Diagnostics System Revenue by Players (US$ Million) & (2021-2026) Table 18. Global AI Imaging and Diagnostics System Revenue Market Share by Players (2021-2026) Table 19. Global AI Imaging and Diagnostics System Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global AI Imaging and Diagnostics System Key Players Headquarters & Area Served Table 21. Global AI Imaging and Diagnostics System Players, Product Type & Application Table 22. Global AI Imaging and Diagnostics System Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global AI Imaging and Diagnostics System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global AI Imaging and Diagnostics System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI Imaging and Diagnostics System Revenue by Type (2021-2026) & (US$ Million) Table 27. Global AI Imaging and Diagnostics System Revenue by Type (2027-2032) & (US$ Million) Table 28. Global AI Imaging and Diagnostics System Revenue Market Share by Type (2021-2026) Table 29. Global AI Imaging and Diagnostics System Revenue Market Share by Type (2027-2032) Table 30. Global AI Imaging and Diagnostics System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Imaging and Diagnostics System Revenue by Application (2021-2026) & (US$ Million) Table 32. Global AI Imaging and Diagnostics System Revenue by Application (2027-2032) & (US$ Million) Table 33. Global AI Imaging and Diagnostics System Revenue Market Share by Application (2021-2026) Table 34. Global AI Imaging and Diagnostics System Revenue Market Share by Application (2027-2032) Table 35. Siemens Healthineers AG Company Information Table 36. Siemens Healthineers AG Business Overview Table 37. Siemens Healthineers AG AI Imaging and Diagnostics System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Siemens Healthineers AG AI Imaging and Diagnostics System Product Portfolio Table 39. Siemens Healthineers AG Recent Development Table 40. GE Healthcare Company Information Table 41. GE Healthcare Business Overview Table 42. GE Healthcare AI Imaging and Diagnostics System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. GE Healthcare AI Imaging and Diagnostics System Product Portfolio Table 44. GE Healthcare Recent Development Table 45. IBM Watson Health Company Information Table 46. IBM Watson Health Business Overview Table 47. IBM Watson Health AI Imaging and Diagnostics System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. IBM Watson Health AI Imaging and Diagnostics System Product Portfolio Table 49. IBM Watson Health Recent Development Table 50. Philips Healthcare Company Information Table 51. Philips Healthcare Business Overview Table 52. Philips Healthcare AI Imaging and Diagnostics System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Philips Healthcare AI Imaging and Diagnostics System Product Portfolio Table 54. Philips Healthcare Recent Development Table 55. AliveCor Inc. Company Information Table 56. AliveCor Inc. Business Overview Table 57. AliveCor Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. AliveCor Inc. AI Imaging and Diagnostics System Product Portfolio Table 59. AliveCor Inc. Recent Development Table 60. Zebra Medical Vision, Inc. Company Information Table 61. Zebra Medical Vision, Inc. Business Overview Table 62. Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Product Portfolio Table 64. Zebra Medical Vision, Inc. Recent Development Table 65. Riverain Technologies Company Information Table 66. Riverain Technologies Business Overview Table 67. Riverain Technologies AI Imaging and Diagnostics System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Riverain Technologies AI Imaging and Diagnostics System Product Portfolio Table 69. Riverain Technologies Recent Development Table 70. Vuno, Inc. Company Information Table 71. Vuno, Inc. Business Overview Table 72. Vuno, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Vuno, Inc. AI Imaging and Diagnostics System Product Portfolio Table 74. Vuno, Inc. Recent Development Table 75. Aidoc Company Information Table 76. Aidoc Business Overview Table 77. Aidoc AI Imaging and Diagnostics System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Aidoc AI Imaging and Diagnostics System Product Portfolio Table 79. Aidoc Recent Development Table 80. Neural Analytics Company Information Table 81. Neural Analytics Business Overview Table 82. Neural Analytics AI Imaging and Diagnostics System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Neural Analytics AI Imaging and Diagnostics System Product Portfolio Table 84. Neural Analytics Recent Development Table 85. Imagen Technologies Company Information Table 86. Imagen Technologies Business Overview Table 87. Imagen Technologies AI Imaging and Diagnostics System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Imagen Technologies AI Imaging and Diagnostics System Product Portfolio Table 89. Imagen Technologies Recent Development Table 90. Digital Diagnostics, Inc. Company Information Table 91. Digital Diagnostics, Inc. Business Overview Table 92. Digital Diagnostics, Inc. AI Imaging and Diagnostics System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Digital Diagnostics, Inc. AI Imaging and Diagnostics System Product Portfolio Table 94. Digital Diagnostics, Inc. Recent Development Table 95. Google (Subsidiary of Alphabet, Inc.) Company Information Table 96. Google (Subsidiary of Alphabet, Inc.) Business Overview Table 97. Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Product Portfolio Table 99. Google (Subsidiary of Alphabet, Inc.) Recent Development Table 100. Heartflow Company Information Table 101. Heartflow Business Overview Table 102. Heartflow AI Imaging and Diagnostics System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Heartflow AI Imaging and Diagnostics System Product Portfolio Table 104. Heartflow Recent Development Table 105. Digital Diagnostics (Formerly Known as Idx) Company Information Table 106. Digital Diagnostics (Formerly Known as Idx) Business Overview Table 107. Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Product Portfolio Table 109. Digital Diagnostics (Formerly Known as Idx) Recent Development Table 110. North America AI Imaging and Diagnostics System Revenue by Type (2021-2026) & (US$ Million) Table 111. North America AI Imaging and Diagnostics System Revenue by Type (2027-2032) & (US$ Million) Table 112. North America AI Imaging and Diagnostics System Revenue by Application (2021-2026) & (US$ Million) Table 113. North America AI Imaging and Diagnostics System Revenue by Application (2027-2032) & (US$ Million) Table 114. North America AI Imaging and Diagnostics System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America AI Imaging and Diagnostics System Revenue by Country (2021-2026) & (US$ Million) Table 116. North America AI Imaging and Diagnostics System Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe AI Imaging and Diagnostics System Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe AI Imaging and Diagnostics System Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe AI Imaging and Diagnostics System Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe AI Imaging and Diagnostics System Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe AI Imaging and Diagnostics System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe AI Imaging and Diagnostics System Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe AI Imaging and Diagnostics System Revenue by Country (US$ Million) & (2027-2032) Table 124. China AI Imaging and Diagnostics System Revenue by Type (2021-2026) & (US$ Million) Table 125. China AI Imaging and Diagnostics System Revenue by Type (2027-2032) & (US$ Million) Table 126. China AI Imaging and Diagnostics System Revenue by Application (2021-2026) & (US$ Million) Table 127. China AI Imaging and Diagnostics System Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia AI Imaging and Diagnostics System Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia AI Imaging and Diagnostics System Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia AI Imaging and Diagnostics System Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia AI Imaging and Diagnostics System Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia AI Imaging and Diagnostics System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia AI Imaging and Diagnostics System Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia AI Imaging and Diagnostics System Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA AI Imaging and Diagnostics System Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA AI Imaging and Diagnostics System Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA AI Imaging and Diagnostics System Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA AI Imaging and Diagnostics System Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA AI Imaging and Diagnostics System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA AI Imaging and Diagnostics System Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA AI Imaging and Diagnostics System Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. AI Imaging and Diagnostics System Image Figure 2. Global AI Imaging and Diagnostics System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Imaging and Diagnostics System Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hardware Image Figure 5. Software Image Figure 6. Global AI Imaging and Diagnostics System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global AI Imaging and Diagnostics System Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Diagnostic Centers Image Figure 10. Others Image Figure 11. Global AI Imaging and Diagnostics System Market Size (US$ Million) & (2021-2032) Figure 12. Global AI Imaging and Diagnostics System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global AI Imaging and Diagnostics System Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global AI Imaging and Diagnostics System Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global AI Imaging and Diagnostics System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI Imaging and Diagnostics System Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global AI Imaging and Diagnostics System Revenue Market Share by Type (2021-2032) Figure 19. Global AI Imaging and Diagnostics System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI Imaging and Diagnostics System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global AI Imaging and Diagnostics System Revenue Market Share by Application (2021-2032) Figure 22. North America AI Imaging and Diagnostics System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America AI Imaging and Diagnostics System Revenue Share by Type (2021-2032) Figure 24. North America AI Imaging and Diagnostics System Revenue Share by Application (2021-2032) Figure 25. North America AI Imaging and Diagnostics System Revenue Share by Country (2021-2032) Figure 26. United States AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe AI Imaging and Diagnostics System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe AI Imaging and Diagnostics System Revenue Share by Type (2021-2032) Figure 31. Europe AI Imaging and Diagnostics System Revenue Share by Application (2021-2032) Figure 32. Europe AI Imaging and Diagnostics System Revenue Share by Country (2021-2032) Figure 33. Germany AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China AI Imaging and Diagnostics System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China AI Imaging and Diagnostics System Revenue Share by Type (2021-2032) Figure 43. China AI Imaging and Diagnostics System Revenue Share by Application (2021-2032) Figure 44. Asia AI Imaging and Diagnostics System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia AI Imaging and Diagnostics System Revenue Share by Type (2021-2032) Figure 46. Asia AI Imaging and Diagnostics System Revenue Share by Application (2021-2032) Figure 47. Asia AI Imaging and Diagnostics System Revenue Share by Region (2021-2032) Figure 48. Japan AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA AI Imaging and Diagnostics System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA AI Imaging and Diagnostics System Revenue Share by Type (2021-2032) Figure 56. SAMEA AI Imaging and Diagnostics System Revenue Share by Application (2021-2032) Figure 57. SAMEA AI Imaging and Diagnostics System Revenue Share by Country (2021-2032) Figure 58. Brazil AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt AI Imaging and Diagnostics System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software
Applications
  • Hospitals
  • Diagnostic Centers
  • Others
Companies covered
  • Siemens Healthineers AG
  • GE Healthcare
  • IBM Watson Health
  • Philips Healthcare
  • AliveCor Inc.
  • Zebra Medical Vision, Inc.
  • Riverain Technologies
  • Vuno, Inc.
  • Aidoc
  • Neural Analytics
  • Imagen Technologies
  • Digital Diagnostics, Inc.
  • Google (Subsidiary of Alphabet, Inc.)
  • Heartflow
  • Digital Diagnostics (Formerly Known as Idx)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Imaging and Diagnostics System Market by Type
  3. 1.2.1 Global AI Imaging and Diagnostics System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hardware
  5. 1.2.3 Software
  6. 1.3 AI Imaging and Diagnostics System Market by Application
  7. 1.3.1 Global AI Imaging and Diagnostics System Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Diagnostic Centers
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 AI Imaging and Diagnostics System Market Dynamics
  1. 2.1 AI Imaging and Diagnostics System Industry Trends
  2. 2.2 AI Imaging and Diagnostics System Industry Drivers
  3. 2.3 AI Imaging and Diagnostics System Industry Opportunities and Challenges
  4. 2.4 AI Imaging and Diagnostics System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Imaging and Diagnostics System Market Perspective (2021-2032)
  2. 3.2 Global AI Imaging and Diagnostics System Growth Trends by Region
  3. 3.2.1 Global AI Imaging and Diagnostics System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Imaging and Diagnostics System Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Imaging and Diagnostics System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Imaging and Diagnostics System Revenue by Players
  2. 4.1.1 Global AI Imaging and Diagnostics System Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Imaging and Diagnostics System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Imaging and Diagnostics System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Imaging and Diagnostics System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Imaging and Diagnostics System Key Players Headquarters & Area Served
  7. 4.4 Global AI Imaging and Diagnostics System Players, Product Type & Application
  8. 4.5 Global AI Imaging and Diagnostics System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Imaging and Diagnostics System Market CR5 and HHI
  11. 4.6.3 2025 AI Imaging and Diagnostics System Tier 1, Tier 2, and Tier 3
5 AI Imaging and Diagnostics System Market Size by Type
  1. 5.1 Global AI Imaging and Diagnostics System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Imaging and Diagnostics System Revenue by Type (2021-2032)
  3. 5.3 Global AI Imaging and Diagnostics System Revenue Market Share by Type (2021-2032)
6 AI Imaging and Diagnostics System Market Size by Application
  1. 6.1 Global AI Imaging and Diagnostics System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Imaging and Diagnostics System Revenue by Application (2021-2032)
  3. 6.3 Global AI Imaging and Diagnostics System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Siemens Healthineers AG
  2. 7.1.1 Siemens Healthineers AG Company Information
  3. 7.1.2 Siemens Healthineers AG Business Overview
  4. 7.1.3 Siemens Healthineers AG AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Siemens Healthineers AG AI Imaging and Diagnostics System Product Portfolio
  6. 7.1.5 Siemens Healthineers AG Recent Developments
  7. 7.2 GE Healthcare
  8. 7.2.1 GE Healthcare Company Information
  9. 7.2.2 GE Healthcare Business Overview
  10. 7.2.3 GE Healthcare AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GE Healthcare AI Imaging and Diagnostics System Product Portfolio
  12. 7.2.5 GE Healthcare Recent Developments
  13. 7.3 IBM Watson Health
  14. 7.3.1 IBM Watson Health Company Information
  15. 7.3.2 IBM Watson Health Business Overview
  16. 7.3.3 IBM Watson Health AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 IBM Watson Health AI Imaging and Diagnostics System Product Portfolio
  18. 7.3.5 IBM Watson Health Recent Developments
  19. 7.4 Philips Healthcare
  20. 7.4.1 Philips Healthcare Company Information
  21. 7.4.2 Philips Healthcare Business Overview
  22. 7.4.3 Philips Healthcare AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Philips Healthcare AI Imaging and Diagnostics System Product Portfolio
  24. 7.4.5 Philips Healthcare Recent Developments
  25. 7.5 AliveCor Inc.
  26. 7.5.1 AliveCor Inc. Company Information
  27. 7.5.2 AliveCor Inc. Business Overview
  28. 7.5.3 AliveCor Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 AliveCor Inc. AI Imaging and Diagnostics System Product Portfolio
  30. 7.5.5 AliveCor Inc. Recent Developments
  31. 7.6 Zebra Medical Vision, Inc.
  32. 7.6.1 Zebra Medical Vision, Inc. Company Information
  33. 7.6.2 Zebra Medical Vision, Inc. Business Overview
  34. 7.6.3 Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Product Portfolio
  36. 7.6.5 Zebra Medical Vision, Inc. Recent Developments
  37. 7.7 Riverain Technologies
  38. 7.7.1 Riverain Technologies Company Information
  39. 7.7.2 Riverain Technologies Business Overview
  40. 7.7.3 Riverain Technologies AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Riverain Technologies AI Imaging and Diagnostics System Product Portfolio
  42. 7.7.5 Riverain Technologies Recent Developments
  43. 7.8 Vuno, Inc.
  44. 7.8.1 Vuno, Inc. Company Information
  45. 7.8.2 Vuno, Inc. Business Overview
  46. 7.8.3 Vuno, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Vuno, Inc. AI Imaging and Diagnostics System Product Portfolio
  48. 7.8.5 Vuno, Inc. Recent Developments
  49. 7.9 Aidoc
  50. 7.9.1 Aidoc Company Information
  51. 7.9.2 Aidoc Business Overview
  52. 7.9.3 Aidoc AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Aidoc AI Imaging and Diagnostics System Product Portfolio
  54. 7.9.5 Aidoc Recent Developments
  55. 7.10 Neural Analytics
  56. 7.10.1 Neural Analytics Company Information
  57. 7.10.2 Neural Analytics Business Overview
  58. 7.10.3 Neural Analytics AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Neural Analytics AI Imaging and Diagnostics System Product Portfolio
  60. 7.10.5 Neural Analytics Recent Developments
  61. 7.11 Imagen Technologies
  62. 7.11.1 Imagen Technologies Company Information
  63. 7.11.2 Imagen Technologies Business Overview
  64. 7.11.3 Imagen Technologies AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Imagen Technologies AI Imaging and Diagnostics System Product Portfolio
  66. 7.11.5 Imagen Technologies Recent Developments
  67. 7.12 Digital Diagnostics, Inc.
  68. 7.12.1 Digital Diagnostics, Inc. Company Information
  69. 7.12.2 Digital Diagnostics, Inc. Business Overview
  70. 7.12.3 Digital Diagnostics, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Digital Diagnostics, Inc. AI Imaging and Diagnostics System Product Portfolio
  72. 7.12.5 Digital Diagnostics, Inc. Recent Developments
  73. 7.13 Google (Subsidiary of Alphabet, Inc.)
  74. 7.13.1 Google (Subsidiary of Alphabet, Inc.) Company Information
  75. 7.13.2 Google (Subsidiary of Alphabet, Inc.) Business Overview
  76. 7.13.3 Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Product Portfolio
  78. 7.13.5 Google (Subsidiary of Alphabet, Inc.) Recent Developments
  79. 7.14 Heartflow
  80. 7.14.1 Heartflow Company Information
  81. 7.14.2 Heartflow Business Overview
  82. 7.14.3 Heartflow AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Heartflow AI Imaging and Diagnostics System Product Portfolio
  84. 7.14.5 Heartflow Recent Developments
  85. 7.15 Digital Diagnostics (Formerly Known as Idx)
  86. 7.15.1 Digital Diagnostics (Formerly Known as Idx) Company Information
  87. 7.15.2 Digital Diagnostics (Formerly Known as Idx) Business Overview
  88. 7.15.3 Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Product Portfolio
  90. 7.15.5 Digital Diagnostics (Formerly Known as Idx) Recent Developments
8 North America
  1. 8.1 North America AI Imaging and Diagnostics System Revenue (2021-2032)
  2. 8.2 North America AI Imaging and Diagnostics System Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Imaging and Diagnostics System Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Imaging and Diagnostics System Revenue by Type (2027-2032)
  5. 8.3 North America AI Imaging and Diagnostics System Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Imaging and Diagnostics System Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Imaging and Diagnostics System Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Imaging and Diagnostics System Revenue by Application (2027-2032)
  9. 8.5 North America AI Imaging and Diagnostics System Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Imaging and Diagnostics System Revenue by Country
  11. 8.6.1 North America AI Imaging and Diagnostics System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Imaging and Diagnostics System Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Imaging and Diagnostics System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Imaging and Diagnostics System Revenue (2021-2032)
  2. 9.2 Europe AI Imaging and Diagnostics System Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Imaging and Diagnostics System Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Imaging and Diagnostics System Revenue by Type (2027-2032)
  5. 9.3 Europe AI Imaging and Diagnostics System Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Imaging and Diagnostics System Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Imaging and Diagnostics System Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Imaging and Diagnostics System Revenue by Application (2027-2032)
  9. 9.5 Europe AI Imaging and Diagnostics System Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Imaging and Diagnostics System Revenue by Country
  11. 9.6.1 Europe AI Imaging and Diagnostics System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Imaging and Diagnostics System Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Imaging and Diagnostics System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Imaging and Diagnostics System Revenue (2021-2032)
  2. 10.2 China AI Imaging and Diagnostics System Revenue by Type (2021-2032)
  3. 10.2.1 China AI Imaging and Diagnostics System Revenue by Type (2021-2026)
  4. 10.2.2 China AI Imaging and Diagnostics System Revenue by Type (2027-2032)
  5. 10.3 China AI Imaging and Diagnostics System Revenue Share by Type (2021-2032)
  6. 10.4 China AI Imaging and Diagnostics System Revenue by Application (2021-2032)
  7. 10.4.1 China AI Imaging and Diagnostics System Revenue by Application (2021-2026)
  8. 10.4.2 China AI Imaging and Diagnostics System Revenue by Application (2027-2032)
  9. 10.5 China AI Imaging and Diagnostics System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Imaging and Diagnostics System Revenue (2021-2032)
  2. 11.2 Asia AI Imaging and Diagnostics System Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Imaging and Diagnostics System Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Imaging and Diagnostics System Revenue by Type (2027-2032)
  5. 11.3 Asia AI Imaging and Diagnostics System Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Imaging and Diagnostics System Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Imaging and Diagnostics System Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Imaging and Diagnostics System Revenue by Application (2027-2032)
  9. 11.5 Asia AI Imaging and Diagnostics System Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Imaging and Diagnostics System Revenue by Country
  11. 11.6.1 Asia AI Imaging and Diagnostics System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Imaging and Diagnostics System Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Imaging and Diagnostics System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Imaging and Diagnostics System Revenue (2021-2032)
  2. 12.2 SAMEA AI Imaging and Diagnostics System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Imaging and Diagnostics System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Imaging and Diagnostics System Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Imaging and Diagnostics System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Imaging and Diagnostics System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Imaging and Diagnostics System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Imaging and Diagnostics System Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Imaging and Diagnostics System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Imaging and Diagnostics System Revenue by Country
  11. 12.6.1 SAMEA AI Imaging and Diagnostics System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Imaging and Diagnostics System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Imaging and Diagnostics System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research